Do the New DAPT Guidelines Result in Any Real Changes in Practice? - Cardiac Interventions Today
Dapt and triple therapy newsletter and chart
Antithrombotic therapy after an ACS in atrial fibrillation patients... | Download Scientific Diagram
Dual antiplatelet therapy for secondary prevention of coronary artery disease | Open Heart
Fernando de la Guía 🩺 on Twitter: "Atrial fibrillation patients undergoing PCI for NSTE-ACS. Triple therapy (N)OAC + DAPT up to 1 week (in hospital) and after... 🧐 and finally (N)OAC alone! #
Atrial fibrillation with percutaneous coronary intervention: Navigating the minefield of antithrombotic therapies - Atherosclerosis
ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison - ScienceDirect
Antiplatelet therapy in coronary artery disease
Figure 2 | Antithrombotic therapy after percutaneous coronary intervention from the Japanese perspective | SpringerLink
Cardiovascular Medicine - Novel directions for the management of dual antiplatelet therapy in patients with coronary artery disease
Dapt Review
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention | Circulation
Algorithm for dual antiplatelet therapy (DAPT) in patients treated with... | Download Scientific Diagram
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention | Circulation
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review - ScienceDirect
Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the
Antithrombotic therapy after pci in atrial fibrillation 2016
JCM | Free Full-Text | Diagnosis and Management of Acute Coronary Syndrome: What is New and Why? Insight From the 2020 European Society of Cardiology Guidelines | HTML
Duration of triple therapy in patients requiring oral
RE-DUAL PCI™ vs PIONEER AF-PCI™
Update on antithrombotic therapy after percutaneous coronary revascularisation.,The Lancet - X-MOL
Cardiovascular Medicine - Novel directions for the management of dual antiplatelet therapy in patients with coronary artery disease
Questions Remain on DAPT Prolongation | DAIC
